Related Experiment Video
Updated: Aug 9, 2026

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
Published on: July 25, 2020
Implementation of guidelines and paths in oncology
1University of Texas, M.D., Anderson Cancer Center, Houston, USA.
Abstract:
At the M.D. Anderson Cancer Center, we initiated a disease management program to reduce the variability of practice and increase its effectiveness, using a model that was familiar to the faculty. Professional staff members, including physicians, nurses, and allied health professionals, were divided into groups according to disease site. Each group developed practice guidelines and collaborative care paths based on evidence in the literature and expert opinion. Desired outcomes were defined. The faculty participated in developing and implementing the program, which was viewed as a means of achieving efficient, productive management of care. Nearly 1,000 patients have been entered on the 98 paths outlined to date. Integrated information systems have been an important tool for instituting the guidelines at the point of patient care and for measuring clinical and financial outcomes. A physician-led outcomes management program should permit us to deliver high-quality care and support outcomes research while decreasing costs.
More Related Videos
08:52Profiling Sensitivity to Targeted Therapies in EGFR-Mutant NSCLC Patient-Derived Organoids
Published on: November 22, 2021
08:26Strategy for Biobanking of Ovarian Cancer Organoids: Addressing the Interpatient Heterogeneity across Histological Subtypes and Disease Stages
Published on: February 23, 2024
Related Concept Videos
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Treatment Resistant Cancers
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Treatment Resistent Cancers
Cancer Survival Analysis